1-15 of 15
Judith D. Goldberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Clinical Trials & Observations
John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N. Harrison, Mary Frances McMullin, Alessandro M. Vannucchi, Joanne Ewing, Casey L. O'Connell, Jean-Jacques Kiladjian, Adam J. Mead, Elliott F. Winton, David S. Leibowitz, Valerio De Stefano, Murat O. Arcasoy, Craig M. Kessler, Rosalind Catchatourian, Damiano Rondelli, Richard T. Silver, Andrea Bacigalupo, Arnon Nagler, Marina Kremyanskaya, Max F. Levine, Juan E. Arango Ossa, Erin McGovern, Lonette Sandy, Mohamad E. Salama, Vesna Najfeld, Joseph Tripodi, Noushin Farnoud, Alexander V. Penson, Rona Singer Weinberg, Leah Price, Judith D. Goldberg, Tiziano Barbui, Roberto Marchioli, Gianni Tognoni, Raajit K. Rampal, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman
Journal: Blood
Blood (2022) 139 (19): 2931–2941.
https://doi.org/10.1182/blood.2021012743
Published: 2022
Includes: Supplemental data
Journal Articles

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Clinical Trials & Observations
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, Josef T. Prchal, Dmitry Berenzon, Maria R. Baer, Ellen Ritchie, Richard T. Silver, Craig Kessler, Elliott Winton, Maria Chiara Finazzi, Alessandro Rambaldi, Alessandro M. Vannucchi, David Leibowitz, Damiano Rondelli, Murat O. Arcasoy, Rosalind Catchatourian, Joseph Vadakara, Vittorio Rosti, Elizabeth Hexner, Marina Kremyanskaya, Lonette Sandy, Joseph Tripodi, Vesna Najfeld, Noushin Farnoud, Elli Papaemmanuil, Mohamed Salama, Rona Singer-Weinberg, Raajit Rampal, Judith D. Goldberg, Tiziano Barbui, Ruben Mesa, Amylou C. Dueck, Ronald Hoffman
Journal: Blood
Blood (2019) 134 (18): 1498–1509.
https://doi.org/10.1182/blood.2019000428
Published: 2019
Includes: Supplemental data
Journal Articles

Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 Randomized Trial of Pegylated Interferon Alfa-2a (PEG) Versus Hydroxyurea (HU) Therapy for the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET)

John Mascarenhas, MD, Heidi E. Kosiorek, MS, Josef T. Prchal, MD, Alessandro Rambaldi, MD, Dmitriy Berenzon, MD, Abdulraheem Yacoub, MD, Claire N. Harrison, MD DM, FRCP, PRCPath, Mary Frances McMullin, MD, Alessandro M. Vannucchi, MD, Joanne Ewing, PhD BMBS, BSc, FRPATH,, Casey L. O'Connell, MD, Jean-Jacques Kiladjian, MD PhD, Adam J. Mead, MD PhD, Elliott F. Winton, MD, David S. Leibowitz, MD, Valerio De Stefano, MD, Murat O. Arcasoy, MD, Craig M. Kessler, Rosalind Catchatourian, MD, Damiano Rondelli, MD, Richard T. Silver, MD, Andrea Bacigalupo, MD, Arnon Nagler, MD, Marina Kremyanskaya, MD PhD, Lonette Sandy, Mohamed E. Salama, MD, Vesna Najfeld, PhD, Joseph Tripodi, Rona Singer Weinberg, PhD, Leah Price, Judith D Goldberg, ScD, Raajit K. Rampal, MD PhD, Ruben A. Mesa, MD FACP, Amylou C. Dueck, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 577.
https://doi.org/10.1182/blood-2018-99-111946
Published: 2018
Journal Articles

Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia Who Are Either Hydroxyurea-Resistant or Intolerant: Final Results of the Myeloproliferative Disorders-Research Consortium (MPD-RC) Protocol 111 Global Phase II Trial

Abdulraheem Yacoub, MD, John Mascarenhas, MD, Heidi Elizabeth Kosiorek, MS, Josef T. Prchal, MD, Dmitriy Berenzon, MD, Maria R. Baer, MD, Ellen K Ritchie, MD, Richard T Silver, MD, Craig M. Kessler, MD, Elliott F. Winton, MD, Maria Chiara Finazzi, MD, Alessandro Rambaldi, MD Prof, Alessandro M. Vannucchi, David S. Leibowitz, MD, Damiano Rondelli, MD, Murat O. Arcasoy, MD, Rosalind Catchatourian, MD, Joseph Vadakara, MBBS, Vittorio Rosti, MD, Elizabeth Hexner, MDMS, Marina Kremyanskaya, MD PhD, Alicia Orellana, MD MPH, Lonette Sandy, Joseph Tripodi, Vesna Najfeld, PhD, Mohamed E. Salama, MD, Rona Singer Weinberg, PhD, Raajit K. Rampal, MD PhD, Ruben A Mesa, MD, Judith D Goldberg, ScD, Amylou C. Dueck, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 321.
https://doi.org/10.1182/blood.V130.Suppl_1.321.321
Published: 2017
Journal Articles

Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells

Min Lu, Lijuan Xia, Yen-Chun Liu, Tsivia Hochman, Laetizia Bizzari, Daniel Aruch, Jane Lew, Rona Weinberg, Judith D. Goldberg, Ronald Hoffman
Journal: Blood
Blood (2015) 126 (8): 972–982.
https://doi.org/10.1182/blood-2014-12-618595
Published: 2015
Includes: Supplemental data
Journal Articles

The Effects of Lipocalin (LCN2) on Hematopoiesis in Primary Myelofibrosis

Min Lu, PhD MD, Lijuan Xia, Yen-Chun Liu, Tsivia Hochman, Rona Singer Weinberg, PhD, Judith D Goldberg, Ronald Hoffman
Journal: Blood
Blood (2014) 124 (21): 1878.
https://doi.org/10.1182/blood.V124.21.1878.1878
Published: 2014
Journal Articles

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

Damiano Rondelli, Judith D. Goldberg, Luis Isola, Leah S. Price, Tsiporah B. Shore, Michael Boyer, Andrea Bacigalupo, Alessandro Rambaldi, Marco Scarano, Rebecca B. Klisovic, Vikas Gupta, Bjorn Andreasson, John Mascarenhas, Meir Wetzler, Alessandro M. Vannucchi, Josef T. Prchal, Vesna Najfeld, Attilio Orazi, Rona S. Weinberg, Crystal Miller, Giovanni Barosi, Lewis R. Silverman, Giuseppe Prosperini, Roberto Marchioli, Ronald Hoffman
Journal: Blood
Blood (2014) 124 (7): 1183–1191.
https://doi.org/10.1182/blood-2014-04-572545
Published: 2014
Journal Articles

Characterization of the TGF-β1 signaling abnormalities in the Gata1 low mouse model of myelofibrosis

Maria Zingariello, Fabrizio Martelli, Fiorella Ciaffoni, Francesca Masiello, Barbara Ghinassi, Emanuela D’Amore, Margherita Massa, Giovanni Barosi, Laura Sancillo, Xiaochun Li, Judith D. Goldberg, Rosa Alba Rana, Anna Rita Migliaccio
Journal: Blood
Blood (2013) 121 (17): 3345–3363.
https://doi.org/10.1182/blood-2012-06-439661
Published: 2013
Includes: Supplemental data
Journal Articles

Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis

Damiano Rondelli, MD, Judith D. Goldberg, Sc.D., Roberto Marchioli, MPH, Luis Isola, MD, Tsiporah B. Shore, MD, Josef T. Prchal, MD, Andrea Bacigalupo, MD, Alessandro Rambaldi, Rebecca B. Klisovic, MD, Vikas Gupta, MD, FRCP, FRCPath, Bjorn Andreasson, MD, Erin P. Demakos, RN, Leah S. Price, Sc.D., Marco Scarano, Sc.D., Meir Wetzler, MD, Alessandro M. Vannucchi, MD, Vesna Najfeld, PhD, Giovanni Barosi, MD, Lewis R. Silverman, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2011) 118 (21): 1750.
https://doi.org/10.1182/blood.V118.21.1750.1750
Published: 2011
Journal Articles

Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis

John Mascarenhas, MD, Alice Mercado, RN, Amelyn Rodriguez, BSN, RN, OCN, Min Lu, PhD, Carla Kalvin, Xiaochun Li, PhD, Bruce Petersen, MD, Vesna Najfeld, PhD, Judith D. Goldberg, Sc.D., Ronald Hoffman, MD
Journal: Blood
Blood (2011) 118 (21): 794.
https://doi.org/10.1182/blood.V118.21.794.794
Published: 2011
Journal Articles

A Phase I Study of LBH589, a Novel Histone Deacetylase Inhibitor in Patients with Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF).

John Mascarenhas, MD, Xiaoli Wang, MD, PhD, Amelyn Rodriguez, BSN, RN, OCN, Mingjiang Xu, MD, PhD, Elaine Gorman, ANP-BC, Wenyong Zhang, MD, PhD, Judith D. Goldberg, Sc.D., Vesna Najfeld, Ph.D., Ronald Hoffman, MD
Journal: Blood
Blood (2009) 114 (22): 308.
https://doi.org/10.1182/blood.V114.22.308.308
Published: 2009
Journal Articles

Thrombopoietin Receptor (MPL) Genotype Modifies the Myeloproliferative Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera.

Jerry L. Spivak, MD, Donna M Williams, Brady L. Stein, MD, Ophelia Rogers, Tsivia Hochman, MS, Judith D. Goldberg, Sc.D., Wanming Zhao, Zhizhuang Joe Zhao, Alison R Moliterno, MD
Journal: Blood
Blood (2009) 114 (22): 964.
https://doi.org/10.1182/blood.V114.22.964.964
Published: 2009
Journal Articles

A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC).

Elizabeth Hexner, MD, Judith D. Goldberg, Sc.D., Josef T. Prchal, MD, Erin P Demakos, RN, Sabina Swierczek, Ph.D., Rona Singer Weinberg, PhD, Joseph Tripodi, M.S., Vesna Najfeld, Ph.D., Martin Carroll, MD, Roberto Marchioli, MD, Lewis R. Silverman, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2009) 114 (22): 754.
https://doi.org/10.1182/blood.V114.22.754.754
Published: 2009
Journal Articles

Correlation of Novel Molecular Markers in Patients with Myeloproliferative Neoplasms.

Kai Kaufmann, Sabina Swierczek, PhD, Shulian Shang, Albert Gruender, PhD, Rona Singer Weinberg, PhD, Alessandro Rambaldi, MD, Roberto Marchioli, MD, Kimberly Hickmann, Judith D. Goldberg, ScD, Josef T. Prchal, MD, Heike L. Pahl, PhD
Journal: Blood
Blood (2009) 114 (22): 4968.
https://doi.org/10.1182/blood.V114.22.4968.4968
Published: 2009
Journal Articles

Abnormal P-Selectin Localization During Megakaryocyte Development Determines Thrombosis in the Gata1 low Model of Myelofibrosis.

Eva Zetterberg, MD, PhD, Maria Verrucci, Ph.D, Fabrizio Martelli, Ph.D, Barbara Ghinassi, Ph.D, Emanuela D'Amore, Judith D. Goldberg, Sc.D., Anna Rita Migliaccio, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1907.
https://doi.org/10.1182/blood.V114.22.1907.1907
Published: 2009